Diagnostic Imaging Pathways Logo

  • Pathways
  • Normal Anatomy
  • Medical Images
  • Radiation Module
  • Radiation Quiz
  • Menu
  • Search

Angina (Stable, Suspected)

Population Covered By The Guidance

This pathway provides guidance on the imaging investigation of adult patients with suspected stable angina.

Lead Researcher: Sian Chin

Experts & Contributors: Arun Abraham, Ravinder Dhillon, Conor Murray, Rachael O’Rourke, Adil Rajwani, Teck Siew, Yuranga Weerakkody

Editorial Panel: Core membership
Link to Editorial Panel

Date reviewed: May 2018

Date Published: March 2019

No available images

  • The updated Diamond-Forrester model (Genders model) has been shown to have a good level of discrimination between patients with and without stable angina, based on a large contemporary multicentre cohort study 1
  • Patients with atypical or typical angina should be offered diagnostic testing 2
  • The presence of ST-T changes or Q waves on resting ECG warrants further testing even in people with non-anginal pain 2
  • Patients with non-anginal pain should not be routinely investigated for coronary artery disease (CAD) regardless of pre-test probability, unless there are indications to suggest the chest pain may in fact be of cardiac origin 2
  • CTCA is recommended as the first line non-invasive test to evaluate suspected stable chest pain with no prior history of CAD 2
  • CTCA is also the first line investigation to confirm the patency of coronary bypass grafts
  • Patients with prior confirmed CAD should have functional imaging instead of CTCA. 2
  • This includes patients with known ischaemic heart disease, or patients with evidence of coronary artery disease on any previous CT, including non-gated studies
  • If anatomical disease is demonstrated, further stress testing to confirm functional ischaemia is still recommended. 3
  • Severe stenosis may warrant proceeding to catheter angiography with a view to treatment
  • Functional imaging can be used as a second-line test if CTCA show CAD of unknown significance 2
  • Stress echo, MPS and cardiac MR have comparable accuracy so choice of functional test should be based on local and patient factors, taking into consideration availability and radiation exposure 3
  • Invasive catheter angiography is a third-line investigation when results of non-invasive testing are inconclusive 2
  • The overall choice of non-invasive imaging technique depends on various factors, particularly local expertise & availability of services

References are graded from Level I to V according to the Oxford Centre for Evidence-Based Medicine, Levels of Evidence. Download the document

  1. Genders TS, Steyerberg EW, Alkadhi H, Leschka S, Desbiolles L, Nieman K, et al. A clinical prediction rule for the diagnosis of coronary artery disease: validation, updating, and extension. Eur Heart J. 2011;32(11):1316-30. (Level II evidence). View the reference
  2. National Institute for Health and Care Excellence. Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin (update). NICE Guidelines; 2016. (Review article). View the reference
  3. Moss AJ, Williams MC, Newby DE, Nicol ED. The updated NICE guidelines: cardiac CT as the first-line test for coronary artery disease. Current cardiovascular imaging reports. 2017;10(5):15. View the reference
  4. Budoff MJ, Dowe D, Jollis JG, Gitter M, Sutherland J, Halamert E, et al.Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (assessment by coronary computed tomographic angiography of individuals undergoing invasive coronary angiography) trial. J Am Coll Cardiol. 2008. (Level III evidence);52(21):1724-32. View the reference
  5. Meijboom WB, Meijs MF, Schuijf JD, Cramer MJ, Mollet NR, van Mieghem CA, et al. Diagnostic accuracy of 64-slice computed tomography coronary angiography: a prospective, multicenter, multivendor study. J Am Coll Cardiol. 2008. (Level II evidence);52(25):2135-44. View the reference
  6. CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. Lancet. 2015. (Level II evidence);385(9985):2383-91. View the reference
  7. Douglas PS, Hoffmann U, Patel MR, Mark DB, Al-Khalidi HR, Cavanaugh B, et al. Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med. 2015. (Level II evidence);372(14):1291-300. View the reference
  8. McKavanagh P, Lusk L, Ball PA, Verghis RM, Agus AM, Trinick TR, et al. A comparison of cardiac computerized tomography and exercise stress electrocardiogram test for the investigation of stable chest pain: the clinical results of the CAPP randomized prospective trial. European heart journal cardiovascular Imaging. 2015. (Level II evidence);16(4):441-8. View the reference
  9. Gurunathan S, Senior R. Stress echocardiography in stable coronary artery disease. Curr Cardiol Rep. 2017. (Review article);19(12):121. View the reference
  10. Tsutsui JM, Elhendy A, Anderson JR, Xie F, McGrain AC, Porter TR. Prognostic value of dobutamine stress myocardial contrast perfusion echocardiography. Circulation. 2005. (Level III evidence);112(10):1444-50. View the reference
  11. Gaibazzi N, Reverberi C, Lorenzoni V, Molinaro S, Porter TR. Prognostic value of high-dose dipyridamole stress myocardial contrast perfusion echocardiography. Circulation. 2012. (Level III evidence);126(10):1217-24. View the reference
  12. Metz LD, Beattie M, Hom R, Redberg RF, Grady D, Fleischmann KE. The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. J Am Coll Cardiol. 2007. (Level I evidence);49(2):227-37.View the reference
  13. Mangla A, Oliveros E, Williams KA, Sr., Kalra DK. vCardiac imaging in the diagnosis of coronary artery disease. Curr Probl Cardiol. 2017. (Review article);42(10):316-66. View the reference
  14. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European society of cardiology. Eur Heart J. 2013;34(38):2949-3003. (Guideline). View the reference
  15. Mastouri R, Sawada SG, Mahenthiran J. Current noninvasive imaging techniques for detection of coronary artery disease. Expert Rev Cardiovasc Ther. 2010;8(1):77-91. (Review article). View the reference
  16. Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol. 2004. (Level I evidence);11(2):171-85. View the reference
  17. Rausch I, Fuchsel FG, Kuderer C, Hentschel M, Beyer T. Radiation exposure levels of routine SPECT/CT imaging protocols. Eur J Radiol. 2016. (Level II evidence);85(9):1627-36. View the reference
  18. Einstein AJ, Moser KW, Thompson RC, Cerqueira MD, Henzlova MJ. Radiation dose to patients from cardiac diagnostic imaging. Circulation. 2007;116(11):1290. (Review article). View the reference
  19. Mordi IR, Badar AA, Irving RJ, Weir-McCall JR, Houston JG, Lang CC. Efficacy of noninvasive cardiac imaging tests in diagnosis and management of stable coronary artery disease. Vascular health and risk management. 2017. (Review article);13:427-37. View the reference
  20. Aarnoudse WH, Botman KJ, Pijls NH. False-negative myocardial scintigraphy in balanced three-vessel disease, revealed by coronary pressure measurement. Int J Cardiovasc Intervent. 2003. (Level V evidence);5(2):67-71. View the reference
  21. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson. 2013. (Guideline);15:91. View the reference
  22. Roger VL, Jacobsen SJ, Pellikka PA, Miller TD, Bailey KR, Gersh BJ. Prognostic value of treadmill exercise testing: a population-based study in Olmsted County, Minnesota. Circulation. 1998. (Level II evidence);98(25):2836-41. View the reference
  23. Mark DB, Shaw L, Harrell FE, Jr., Hlatky MA, Lee KL, Bengtson JR, et al. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med. 1991. (Level II evidence);325(12):849-53. View the reference
  24. Newman RJ, Darrow M, Cummings DM, King V, Whetstone L, Kelly S, et al. Predictive value of exercise stress testing in a family medicine population. J Am Board Fam Med. 2008. (Level III evidence);21(6):531-8. View the reference
  25. Hamilton-Craig C, Fifoot A, Hansen M, Pincus M, Chan J, Walters DL, et al. Diagnostic performance and cost of CT angiography versus stress ECG--a randomized prospective study of suspected acute coronary syndrome chest pain in the emergency department (CT-COMPARE).Int J Cardiol. 2014. (Level II evidence);177(3):867-73. View the reference
  26. Amsterdam EA, Kirk JD, Diercks DB, Lewis WR, Turnipseed SD. Immediate exercise testing to evaluate low-risk patients presenting to the emergency department with chest pain. J Am Coll Cardiol. 2002. (Level III evidence);40(2):251-6. View the reference
  27. Bennett P, Dyer P. Exercise stress test utility in patients with chest pain presumed to be of cardiac origin. Acute medicine. 2013. (Level III evidence);12(3):146-50. View the reference
  28. Conti A, Gallini C, Costanzo E, Ferri P, Matteini M, Paladini B, et al. Early detection of myocardial ischaemia in the emergency department by rest or exercise (99m)Tc tracer myocardial SPET in patients with chest pain and non-diagnostic ECG. Eur J Nucl Med. 2001. (Level III evidence);28(12):1806-10. View the reference
  29. Gaibazzi N, Reverberi C, Badano L. Usefulness of contrast stress-echocardiography or exercise-electrocardiography to predict long-term acute coronary syndromes in patients presenting with chest pain without electrocardiographic abnormalities or 12-hour troponin elevation. Am J Cardiol. 2011. (Level III evidence);107(2):161-7. View the reference
  30. Shaw LJ, Mieres JH, Hendel RH, Boden WE, Gulati M, Veledar E, et al. Comparative effectiveness of exercise electrocardiography with or without myocardial perfusion single photon emission computed tomography in women with suspected coronary artery disease: results from the what is the optimal method for ischemia evaluation in women (WOMEN) trial. Circulation. 2011. (Level II evidence);124(11):1239-49. View the reference

Pathway User Guide

Yellow Boxes Denotes extra information. Some contain single or multiple white sub-boxes, click a white box to reveal detailed information in a pop-up.

White Boxes: Denotes standard pathway steps. (If inside a yellow box, they open a specific pop-up).

Zoom & Pan Controls: Use + / − or the slider to zoom. Reset returns to default. Tick Panning to drag the diagram when zoomed.

Blue “View Full Screen” Button: Opens the whole diagram in a large, full-screen pop-up window. Use Close to exit.

The relative radiation level (RRL) of each imaging investigation is displayed in the pop up box.

SYMBOL RRL EFFECTIVE DOSE RANGE
No radiation None 0
Minimal radiation Minimal < 1 millisieverts
Low radiation Low 1-5 mSv
Medium radiation Medium 5-10 mSv
High radiation High >10 mSv

Disclaimer

Status Of Recommendations Each pathway is designed to assist clinicians in situations when faced with a large array of possible diagnostic tests and examinations. However, it is recognised that diagnostic practice may differ from a particular pathway depending on local availability of equipment and expertise, as well as the experience of individual clinicians. Therefore each pathway is neither a rigid set of rules, nor a substitute for clinical assessment, and individual patient circumstances should always be considered.

Report an Issue

Spotted an error or outdated info? Click to tell us.

Date reviewed: May 2018 Please note that this pathway is subject to review and revision Prior confirmed CAD 2 criteria or more, or 1 criterion or less with ST-T changes or Q waves on ECG History, physical examination, ECG SUSPECTED STABLE ANGINA • Constricting discomfort in the front of the chest, or in the neck, shoulders, jaw, or arms• Precipitated by physical exertion• Relieved by rest or GTN within about 5 minutes No prior confirmed CAD No CAD, or non-flow limiting lesion <50% stenosis with consideration of embolic infarcts or other causes of chest pain Intervention indicated 1 criterion or less and no ST-T changes or Q waves Consider other causes of chest pain CAD = Coronary artery disease Flow limiting lesion >50% stenosis No previous CABG Consider other causes of chest pain Equivocal result or intervention indicated About Functional Imaging CTCA If ACS suspected, go to the Suspected ACS Pathway Confirm significanceof lesion with functional imaging Invasive Coronary Angiography MPS Stress Echo Cardiac MR Uncertain whether pain is due to myocardial ischaemia Typical anginal pain- treat as stable angina Previous CABG CTCA to confirm patency of grafts Functional imaging or Diamond-Forrester model Criteria for anginal pain:

Diamond-Forrester Model (Genders Model)

Diamond-Forrester Model

0-1 out of 3 = Non-anginal chest pain

2 out of 3 = Atypical angina

All 3 = Typical angina

    • Anginal pain is:
      • Constricting discomfort in the front of the chest, or in the neck, shoulders, jaw, or arms
      • Precipitated by physical exertion
      • Relieved by rest or GTN within about 5 minutes
    • Presence of

one or none

    • of the features is defined as

non-anginal pain

    • Presence of

two

    • features is defined as

atypical angina

    • Presence of

all three

    • features is defined as

typical angina

  • The presence of ST-T changes or Q waves on resting ECG warrants further testing even in people with non-anginal pain
  • Patients with atypical or typical angina should be offered diagnostic testing
  • Patients with non-anginal pain should not be routinely investigated for CAD regardless of pre-test probability, unless there are indications to suggest the chest pain may in fact be of cardiac origin
  • The updated Diamond-Forrester model (Genders model) has been shown to have a good level of discrimination between patients with and without stable angina, based on a large contemporary multicentre cohort study. It is the most well-validated prediction model compared to other models such as the Framingham Risk Score and the Duke Clinical Score

Prior confirmed CAD

Prior confirmed CAD

Prior confirmed CAD includes a history of ischaemic heart disease, or coronary artery disease identified on any previous CT, including non-gated studies

CT Coronary Angiography

CT Coronary Angiography

First line non-invasive investigation for stable cardiac chest pain

    • CT coronary angiography (CTCA) is an established technique that uses contrast to enhance the coronary arteries
    • CTCA is comparable to invasive cardiac angiogram for assessing coronary artery anatomy, but avoids the risks of an invasive procedure
    • A normal CTCA has a high negative predictive value for coronary artery disease, between 97 and 99% ,
    • Multiple studies have validated the accuracy of CTCA to detect coronary artery stenosis. Meta-analysis found CTCA to have a sensitivity of 96% and specificity of 79% for detecting 50% stenosis
    • Currently no statistical difference in mortality or major cardiac events has been demonstrated between patients randomised to CTCA compared with standard treatment,
    • functional testing

    • or stress ECG

  • over an approximately 2 year follow-up period
  • Limitations:
    • Some protocols require the patient to have an optimal target heart rate around 65bpm, and IV beta-blockers may be administered to achieve this. The patient may also need to be able to hold their breath for around 10 seconds
    • Contraindications for CTCA include renal failure, contrast allergy, severe arrhythmia and haemodynamic insufficiency. Coronary arteries cannot be fully evaluated in some patients due to calcifications. With modern techniques and scanners, the radiation dose of a CTCA is around 2-5mSv
  • If anatomical disease is demonstrated, further stress testing to confirm functional ischaemia is still recommended.
  • Severe stenosis may warrant proceeding directly to catheter angiography with a view to treatment
  • Functional imaging may be offered if CTCA shows CAD of uncertain significance or is non-diagnostic

Functional Imaging

Functional Imaging

Stress ECHO, MPS and Cardiac MRI can all assess the presence of stress-related myocardial ischaemia. See ‘About Functional Imaging’ box for more details

  • Functional imaging is performed when subjecting the heart to either exercise or pharmacological stress to assess the presence of stress-related ischaemia
  • Stress echo, MPS and cardiac MR have comparable accuracy so choice of functional test should be based on local and patient factors, taking into consideration availability and radiation exposure

Read about:

Stress ECG

Stress ECG

Affordable and widely available test to demonstrate inducible ischaemia with good prognostic value, though functional imaging tests have a slightly higher sensitivity and specificity. Patients must have an interpretable ECG and be able to exercise

    • Stress electrocardiography (stress ECG) is a widely available and affordable test that can demonstrate reproducible symptoms of cardiac ischaemia
    • Exercise can be performed on a treadmill or exercise bicycle, with exercise increased incrementally until the patient reaches a target heart rate (normally 85% of maximum heart rate) or the patient can no longer continue. A stress ECG test is considered positive if the stress elicits ST segment elevation or depression of ≥0.10 mV
    • Treadmill score correlate well with prognosis.
    • A low risk score has a good prognosis with an associated mortality rate of 0.25% per year compared to 5% per year for a high risk score.

    • The negative predictive value has been found to be over 99%

  • The reported sensitivity is 66-94% with specificity 75-95% with higher sensitivity in specificity in low risk populations (prevalence of NSTEMI or unstable angina ≤10%)
  • The sensitivity and specificity of stress ECG is lower than functional studies, however there are no randomised trials to suggest that this has an adverse effect on patient outcomes ,
  • Limitations:
    • The main limitation with stress ECG is patients with pre-existing ECG changes. These changes (such as left bundle branch block, baseline ST depression, digoxin therapy or pacemakers) make interpretation difficult
    • Patients who are unable to exercise for other reasons, such as musculoskeletal problems, are also not suitable for stress ECG
    • Testing may be inconclusive if the patient is unable to achieve the target heart rate in the absence of symptoms of ischaemia

The presence of anatomical disease cannot be confirmed, so stress ECG is only recommended for patients who have had coronary artery disease previously confirmed with invasive or non-invasive studies

Functional Imaging

Functional Imaging

Stress ECHO, MPS and Cardiac MRI can all assess the presence of stress-related myocardial ischaemia. See ‘About Functional Imaging’ box for more details

  • Functional imaging is performed when subjecting the heart to either exercise or pharmacological stress to assess the presence of stress-related ischaemia
  • Stress echo, MPS and cardiac MR have comparable accuracy so choice of functional test should be based on local and patient factors, taking into consideration availability and radiation exposure

Read about:

Stress Echocardiogram

Stress Echocardiogram

Stress echo and ECG are common screening tests for CAD. Patients are stressed through exercise or pharmacological means

  • Stress echocardiogram (stress echo) is a functional test that can demonstrate cardiac ischaemia
  • The testing method normally occurs as follows. A baseline resting reading is taken. The patient's heart is stressed through exercise (e.g. treadmill, supine bike) or pharmacologically for patients who are unable to exercise (e.g. dobutamine, dipyridamole or adenosine). A second reading is taken while the patient is at peak stress. The two readings are then interpreted together
  • Stress echocardiography (stress echo) is considered positive if there is abnormal ventricular wall motion or thickness in response to stress
  • Contrast echocardiography using microbubbles to show myocardial capillaries can also assess perfusion which improves the diagnostic accuracy of stress echo
  • In meta-analysis, the sensitivity of stress echo was 76-84% to detect 50% stenosis, with a specificity of 79-86%. The specificity is higher (88-90%) for detecting stenosis over 70%
  • A normal stress echo has a good prognosis: normal results are associated with an annual risk of 0.4-0.9% for cardiac mortality or acute myocardial infarction
  • Unlike MPS, there is no radiation dose from stress echo
  • Limitations:
    • As with other forms of ultrasound imaging, the quality and hence overall diagnostic accuracy of echocardiography is limited by the experience of the sonographer and the interpreting physician
    • There is risk associated with inducing stress, with death in 1 in 10 000 and ventricular arrhythmia or MI in 1 in 5 000
    • Dipyridamole and adenosine are relatively contraindicated in severe asthma or profound obstructive pulmonary disease ,
  • Stress echo, MPS and cardiac MR have comparable accuracy so choice of functional test should be based on local and patient factors, taking into consideration availability and radiation exposure
  • If the study is suboptimal and unable to answer the clinical question, for example the acoustic window is restricted due to body habitus, cardiac MR could be considered

Myocardial Perfusion Scintigraphy

Myocardial Perfusion Scintigraphy

MPS is a common screening test for CAD that provides information about myocardial function. It is well validated and highly sensitive and specific for CAD

    • Myocardial perfusion scintigraphy (MPS) using single photon emission computed tomography (SPECT) is a widely available and well validated method of functional cardiac imaging
    • A radioactive tracer (such as technetium-99m or thallium-201) is injected, followed by imaging of the myocardial uptake via SPECT. This is usually done twice; once with the patient at rest and later with the patient under stress, either during exercise or after administration of a vasodilator (such as dipyridamole or adenosine). The images at rest and under stress are assessed together. Areas of myocardium that show reversible defects (i.e. tracer uptake at rest, but not under stress) represent myocardial ischaemia. Areas that show irreversible defects (no tracer uptake at rest or under stress) represent infarcted myocardium
    • Meta-analysis found MPS to have a sensitivity of 78% and specificity of 81% to detect 50% stenosis. MPS combined with CTCA has a sensitivity of 94% and specificity of 95%
    • A normal MPS has a good prognosis: a meta-analysis of 31 studies showed that the rate of death or myocardial infarction was 0.85% per year, which is comparable to event rates in populations without coronary artery disease
    • Limitations:
      • The main disadvantage of MPS is the high radiation dose. Generally, the radiation dose from MPS using technetium-99 is around 7mSv
      • but can be >20mSv with thallium-201

      • – dose also depends on the protocol used
      • MPS is time consuming, taking three to four hours.
      • Some protocols comparing rest and stress images require the tracers to leave the heart which may take up to a week, requiring two visits and delaying results

    • A false negative result may occur when there is widespread ischaemia throughout the whole myocardium, such as in triple vessel disease.
    • This is because the interpretation of the study relies on comparison of ischaemic areas to normal areas
    • There is a 1 in 10 000 risk of death associated with stress induction
  • Stress echo, MPS and cardiac MR have comparable accuracy so choice of functional test should be based on local and patient factors, taking into consideration availability and radiation exposure

Cardiac Magnetic Resonance Imaging

Cardiac Magnetic Resonance Imaging

Cardiac MR is an emerging investigation that can assess cardiac structure and function

    • Cardiac magnetic resonance imaging (cardiac MR) is becoming increasingly used to assess stable coronary artery disease
    • It has the benefit of assessing both coronary artery anatomy and functional ischaemia. Vasodilator techniques use adenosine or regadenoson with gadolinium contrast to assess perfusion defects.
    • Stress cardiac MR can be performed with dobutamine to demonstrate wall motion abnormalities indicating ischaemia

  • Cardiac MR is also accepted as the non-invasive gold standard for assessing cardiac structure and function. Other cardiac conditions that may cause chest pain can be demonstrated on cardiac MR, including Takotsubo cardiomyopathy and myocarditis
  • Cardiac MR has a sensitivity and specificity of 86% for detecting 50% stenosis compared to invasive coronary angiogram
  • There is no associated radiation dose and the safety is comparable to stress echo
  • Limitations ,
    • Availability is one of the main limitations. Access to cardiac MR and reporting expertise is limited
    • Long procedure (approximately 1hr) during which patients must be able to lie still. Scan may not be tolerated due to claustrophobia
    • Incompatible metal implants and foreign bodies are contraindicated in MRI
    • Renal failure is a relative contraindication to gadolinium contrast
    • There is risk of death and cardiac events associated with inducing stress
  • Stress echo, MPS and cardiac MR have comparable accuracy so choice of functional test should be based on local and patient factors, taking into consideration availability and radiation exposure

Invasive Coronary Angiography

Invasive Coronary Angiography

Gold standard for diagnosing anatomical coronary artery disease but carries the risks of an invasive procedure

  • Invasive coronary angiography (ICA) is considered to be the gold standard for diagnosing coronary artery disease
  • Intervention such as balloon angioplasty or stenting may be simultaneously undertaken if disease is found
  • Limitations:
    • ICA is expensive and depends on operator expertise
    • There are risks associated with performing an invasive procedure. Serious risks include stroke, myocardial infarction and death. The rate of non-fatal complications is 74 per 10 000.
    • The side-effects make ICA less acceptable to patients
    • Procedures may take approximately 1.5 hours
    • There is also a significant associated radiation exposure of 4-6mSv
    • There are risks associated with contrast administration and renal failure is a relative contraindication
  • ICA is rarely indicated for diagnosis only; non-invasive imaging techniques are recommended to identify patients who can be managed conservatively and can avoid the risks of an invasive procedure

Suspected ACS Pathway

Suspected ACS Pathway

Go to the pathway

Suspected ACS

SUSPECTED STABLE ANGINA

SUSPECTED STABLE ANGINA

  • Acute Abdomen
  • Breast
  • Cancer Staging
  • Cardiovascular
  • Ear, Nose & Throat
  • Endocrine
  • Gastrointestinal
  • Kidney and Urinary Tract
  • Liver and Biliary
  • Musculoskeletal Non-Trauma
  • Neurological
  • Obstetric & Gynaecological
  • Paediatric
  • Pancreas
  • Respiratory
  • Trauma
    • Trauma - Musculoskeletal
    • Trauma - Head
    • Trauma - Visceral
    • Trauma - Paediatric
  • Cardiovascular

    • Cardiovascular
      • Abdominal aortic aneurysm (Repair follow-up)
      • Abdominal Aortic Aneurysm (Screening and Investigation)
      • Angina (Stable, Suspected)
      • Aortic Dissection (Spontaneous, Suspected)
      • Coronary Syndrome (Acute, Suspected)
      • Deep Venous Thrombosis (Arm, Suspected)
      • Deep Venous Thrombosis (Leg, Suspected)
      • Hypertension
      • Hypertension (Suspected Renovascular Cause)
      • Leg ischaemia (acute)
      • Mesenteric Ischaemia (Chronic, Suspected)
      • Peripheral Arterial Disease (Suspected)
      • Peripheral Arterial Stent (Follow-Up)
    • Respiratory
      • Chest X-Ray (Pre-Operative Indications)

    Diagnostic Imaging Pathways

    The DIP pathways are a step-by-step guides to help clinicians choose the most appropriate imaging for each clinical scenario 

    “Trusted by clinicians worldwide since 2007, Diagnostic Imaging Pathways provides clear, evidence-based imaging guidelines. Our pathways support better decision-making and help improve healthcare outcomes—especially in emerging nations. 

    DIP functions and thrives wholeheartedly under the pillars of diversity, inclusivity and respect for all."

    • Pathways
    • Normal Anatomy
    • Medical Images
    • Radiation Module
    • Radiation Quiz
    • Information for Consumers
    • Governance
    • About Imaging
    • Production
    • Search
    • Login
    • Get in Touch
    © Diagnostic Imaging Pathways (DIP) 2025
    Code of Conduct    Terms and Conditions of Use
    General Site Navigation

    Information For Consumers

    • General Information About Diagnostic Imaging
      • Colorectal (Bowel) Cancer Screening
      • Colorectal (Bowel) Cancer Screening (Australia)
      • Consent to Procedure or Treatment
      • Radiation Risks of X-rays and Scans
    • Imaging Pathways
      • Ankle Injury (Suspected)
      • Bowel Cancer (Staging)
      • Deep Venous Thrombosis ( Leg, Suspected)
      • Deep Venous Thrombosis (Arm, Suspected)
      • Headache (Constant or Repeated)
      • Hip Fracture (Suspected)
      • Hypertension
      • Low Back Pain (Acute)
      • Lung Cancer (Staging)
      • Neck Pain (Non-Traumatic)
      • Renal Colic
      • Respiratory Illness (Acute)
      • Scaphoid Fracture (Suspected)
      • Shoulder (Pain or Instability)
      • Sinusitis (Acute)
      • Sinusitis (Chronic)
      • Stress Fracture (Suspected)
    • Imaging Procedures
      • Angiography (Angiogram)
      • Arthrogram
      • Bone Scan
      • Computed Tomography (CT)
      • Computed Tomography (CT) Angiography
      • Inferior Vena Cava (IVC) Filters
      • Intravenous Pyelogram (IVP)
      • Magnetic Resonance Angiography (MRA)
      • Magnetic Resonance Imaging (MRI)
      • Myelogram
      • Orthopantomogram (OPG)
      • Percutaneous Transthoracic Fine Needle Aspiration (FNA) or Biopsy
      • Positron Emission Tomography (PET)
      • Renal Artery Angioplasty and Stent
      • Renal Scan
      • Ultrasound
      • Ultrasound (Doppler)
      • Ultrasound (Endoscopic Rectal)
      • Venography (Venogram)
      • X-ray (Chest)
      • X-ray (Plain Radiograph)

    Governance

    • History
      • 1990s to 2012
      • 2012 to 2016
      • 2016 to 11 April 2022
      • From 12 April 2022
      • Introduction
      • List of acronyms used on this site
    • Organisation
      • 2003 - 2012
      • 2013 - 2016
      • 2017 - 11 April 2022
      • Post 12 April 2022
    • Personnel
      • Clinical Advisors
      • Contractors
      • Contributors
      • Editor
      • Editorial Panel - Post 2022
      • Editorial Panel - Pre 2022
      • Executive Sponsor
      • Information Technologist
      • Manager
      • Other Personnel
      • Project Officers
      • Quality Coordinator
      • Research Registrar
      • Responsibilites
      • Steering Committee
      • Steering Committee
    • Responsibilities, Achievements
      • Accreditation and Endorsement
      • Clinical Advisors
      • Editor
      • Editorial Panel
      • Executive Sponsor
      • Information Technologist
      • Manager
      • Other Personnel
      • Pathway Creation, Review and Revision
      • Quality Coordinator
      • Research Registrar
      • Steering Committee

    About Imaging

    • About Imaging
      • Bleeding Risk and Assessment
      • General Principles in Requesting and Providing Imaging Investigations
      • Imaging During Pregnancy and Lactation
      • Ionising Radiation in Diagnostic Imaging
      • Ionising Radiation in Paediatric Imaging
    • Common Procedures
      • Computed Tomography
      • Gastrointestinal Contrast Examinations
      • High Resolution Computed Tomography
      • Magnetic Resonance Imaging
      • Nuclear Medicine
      • Positron Emission Tomography
      • Ultrasound
    • Contrast Agents
      • Gadolinium Contrast for MRI scans
      • Iodinated Contrast for CT scans
      • Ultrasound Contrast Media

    Production

    • Editorial Independence
      • Disclosure of Conflict of Interest
      • Funding Policy & Sources
      • Management of Conflict of Interest
    • Processes for Creating and Managing Content
      • Creation of a New Pathway
      • Creation of New Information for Consumers
      • Review and Revision of a Pathway
      • Review and Revision of Information for Consumers
    • Production
      • Initial Engagement with Consumers
      • Principles for Creating and Managing Content